Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aplin and Barrett was a pioneering British biotechnology company best known for the discovery and commercialization of Nisin, a naturally occurring antimicrobial peptide. Founded in 1890 and based in Yeovil, the company transitioned from dairy production to specialized food science and microbiology. Their development of Nisin, marketed under the brand name Nisaplin, revolutionized food preservation by providing a natural alternative to synthetic chemical additives. The company's research into bacteriocins laid the groundwork for modern applications of natural antimicrobials in both food and potential medical contexts. Following its acquisition by Danisco in 1997, the business was eventually integrated into the nutrition and biosciences operations of IFF.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aplin and Barrett.